Skip to main content

Table 1 Patient demographics

From: Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

Characteristics Number of patients (%), n=14
Gender  
Male 13 (93)
female 1 (7)
Age (years)  
Median 58
Range 51-78
Comorbidities  
Chronic cardiac disease 7 (50)
Pulmonary disease 4 (28)
UICC stage  
III 6 (43)
IV 8 (56)
Primary site  
Oropharynx 7 (50)
Hypopharynx 3 (20)
Larynx 2 (15)
Oral cavity 2 (15)